The Centre for Commercialization of Regenerative Medicine (CCRM) is a not-for-profit organization that supports the development of regenerative medicine technologies and cell and gene therapies. It aims to bridge the commercialization gap between research and marketed products by providing business, technical, and manufacturing expertise to companies in the field.

Centre for Commercialization of Regenerative Medicine (CCRM)

MaRS Discovery District

Regenerative Medicine (RM), which aims to harness the power of stem cells, biomaterials and molecules to repair, regenerate or replace diseased cells, tissues and organs, has the promise to treat, manage and perhaps cure some of the most devastating and costly diseases in the world today.

Many new and potentially life-changing RM-based treatments never reach patients because they are not successfully moved from the laboratory to a stage where they can be used in medicine. In order to fulfill RM’s promise to treat the many diseases affecting our population, a world-renowned group of stem cell scientists and engineers have come together to form CCRM, a leader in developing and commercializing regenerative medicine and cell therapy technologies. CCRM formally launched on June 14, 2011.

CCRM supports the development and commercialization of regenerative medicines and associated enabling technologies, with a specific focus on cell and gene therapy. 


CCRM

We are very pleased to share our 2023 #AnnualReport – Future Ready. We hope you will read it and share it. You can find it on our website: https://lnkd.in/gE8_Cxf

Peruse the pages to read about our partnerships, projects, portfolio companies,  people (like our terrific Board of Directors) and progress. 

Shoutouts (and thanks!): Networks of Centres of Excellence, Government of Canada, OmniaBio, McMaster Innovation Park, CCRM Nordic, CCRM Australia, Canadian Advanced Therapies Training Institute, University of Toronto, Centre de production de produits biologiques (CPPB) inc. / Biologics Manufacturing Centre (BMC) Inc., Jim Wilson, Peter Zandstra, McMaster University, Mohawk College, Catamaran Bio, Ontario Veterinary College, University of Guelph, The University of Queensland, Multiplex, Visions of Science , Vinnova, GoCo Health Innovation City, Glenn MacLean, Sarah Lepage, Medicine by Design - University of Toronto, Stem Cell Network and more!!! 

Join us at the Building a Biotech Venture Pitch Competition to cheer on 6 trainee-led entrepreneurial teams as they showcase their innovative technologies for a chance to win $25k or $10k in funding. Held in person at the William Doo Auditorium, 45 Willcocks St., March 27, 3-5pm. Learn more: https://lnkd.in/gqjnK6YV

It's #rarediseaseday and we have the topic covered with lots of interesting blogs related to rare diseases, treatments, advances and more. Pulled from the archives, you can find them here: https://lnkd.in/geSZtyDb

Are you on the path to #commercialization with your medical product? Blogger Laine B. recommends you develop a #communicationstrategy and shares five #tips. Shoutout to Glenn MacLean and #TMM2023 (Stem Cell Network)

https://lnkd.in/gHgVeWZN #pr #publicrelations #scicomm 

msh id	CA:CCRM
symbol	-
name	Centre for Commercialization of Regenerative Medicine (CCRM)
homepage url	https://ccrm.ca
country	CA
sector	Healthcare & Health Services
industry	Biotechnology
market	PRIVATE
employee count	243
crunchbase url	https://www.crunchbase.com/organization/centre-for-commercialization-of-regenerative-medicine
linkedin url	https://www.linkedin.com/company/centre-for-commercialization-of-regenerative-medicine-ccrm-
founders	-

market cap	-
enterprise value	-
stage	-
raised capital	-
valuation	-

monthly webtraffic	-
monthly webtraffic growth	-
growth score 14	10.36
growth score 28	16.39
growth score 90	14.09
growth score 365	13.03

revenue ltm	-
gross profit ltm	-
ebitda ltm	-
net income ltm	-
revenue ntm	-
gross profit ntm	-
ebitda ntm	-
net income ntm	-

growth cost and expenses	-
growth cost of revenue	-
growth depreciation and amortization	-
growth ebitda	-
growth ebitda ratio	-
growth eps	-
growth eps diluted	-
growth general and administrative expenses	-
growth gross profit	-
growth gross profit ratio	-

CA:CCRM

Centre for Commercialization of Regenerative Medicine (CCRM)

Company Information

Market Metrics

Web & Growth Metrics

LTM & NTM Metrics

Growth & Performance Metrics

Operating Metrics

Balance Sheet Metrics

Financial Metrics (2022-2026)

cost and expenses	-
cost of revenue	-
depreciation and amortization	-
ebitda	-
ebitda ratio	-
eps	-
eps diluted	-
operating expenses	-
operating income	-
operating income ratio	-

accounts receivables	-
capital expenditure	-
cash at beginning of period	-
cash at end of period	-
inventory	-
working capital ttm	-

	2022	2023	2024	2025	2026
Revenue Metrics
Revenue	-	-	-	-	-
Revenue Growth	-	-	-	-	-
Revenue Multiple	-	-	-	-	-
Profit Metrics
Gross Profit	-	-	-	-	-
Gross Profit Growth	-	-	-	-	-
Gross Profit Multiple	-	-	-	-	-
EBITDA Metrics
EBITDA	-	-	-	-	-
EBITDA Growth	-	-	-	-	-
EBITDA Multiple	-	-	-	-	-
Net Income Metrics
Net Income	-	-	-	-	-
Net Income Growth	-	-	-	-	-
Net Income Multiple	-	-	-	-	-